Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Under a new Centers for Medicare & Medicaid test, some pioneer accountable care organizations will be given the option of enrolling seniors in an ACO, according to Modern Healthcare.
Geisinger Health System and xG Health Solutions, a company founded by Geisinger in 2013 to commercialize its innovations, have linked their Rheumatology software app to multiple EHR systems by leveraging new draft international standards.
ROSEVILLE, Calif., November 10, 2014 – Intel-GE Care Innovations™, a pioneer in connecting the care continuum to the home, today announced the launch of its latest telehealth technology system, Health Harmony.
A team-based approach can reduce excessive cardiac monitor alarms and therefore alarm desensitization and fatigue, according to a study published in Pediatrics.
WESTBOROUGH, Mass.--eClinicalWorks®, a leader in ambulatory healthcare IT solutions, today announces the success its customers have achieved in receiving National Committee for Quality Assurance (NCQA) Patient-Centered Medical Home (PCMH) recognition.
The physician who treated Ebola patients in West Africa before returning to New York City has been deemed clear of Ebola, meaning that the U.S. currently has no known cases of the virus.
Clinical Data Interchange Standards Consortium and HIMSS, in partnership with Integrating the Healthcare Enterprise, are joining forces to solve the challenge of assessing and reusing EHR data for research purposes within a single workflow.
The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.
The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks.
Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.
